Neuroprotective role of ERK1/2 and ERK5 in a dopaminergic cell line under basal conditions and in response to oxidative stress

Journal of Neuroscience Research

Volumn 84, Issue 6, 2006, Pages 1367-1375

  Cavanaugh, Jane E ^a   Jaumotte, Juliann D ^a   Lakoski, Joan M ^a   Zigmond, Michael J ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

6 hydroxydopamine; Cell death; MAPK; MN9D cells; Parkinson's disease

Indexed keywords

1,4 DIAMINO 1,4 BIS(2 AMINOPHENYLTHIO) 2,3 DICYANOBUTADIENE; DOPAMINE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE 7; OXIDOPAMINE;

ANIMAL CELL; ARTICLE; CELL DEATH; CELL SURVIVAL; DOPAMINERGIC ACTIVITY; DRUG MECHANISM; ENZYME ACTIVATION; ENZYME ACTIVITY; MOUSE; NERVE CELL; NEUROPROTECTION; NEUROTRANSMISSION; NONHUMAN; OXIDATIVE STRESS; PARKINSON DISEASE; PRIORITY JOURNAL; PROTEIN FUNCTION; SIGNAL TRANSDUCTION;

BLOTTING, WESTERN; BUTADIENES; CELL DEATH; CELL LINE; CELL SURVIVAL; CULTURE MEDIA; DOPAMINE; ENZYME INHIBITORS; HUMANS; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; MITOGEN-ACTIVATED PROTEIN KINASE 7; NITRILES; OXIDATIVE STRESS; OXIDOPAMINE; PLASMIDS; TRANSFECTION;

EID: 33750447266     PISSN: 03604012     EISSN: 10974547     Source Type: Journal    
DOI: 10.1002/jnr.21024     Document Type: Article

References (46)

1. Boeckman FA, Aizenman E. 1996. Pharmacological properties of acquired excitotoxicity in Chinese hamster ovary cells transfected with N-methyl-D-aspartate receptor subunits. J Pharmacol Exp Ther 279:515-523.
2. Bonni A, Brunet A, West AE, Datta SR, Takasu MA, Greenberg ME. 1999. Cell survival promoted by the Ras-MAPK signaling pathway by transcription-dependent and -independent mechanisms. Science 286:1358-1362.
3. Brewer GJ. 1995. Serum-free B27/neurobasal medium, supports differentiated growth of neurons from the striatum, substantia nigra, septum, cerebral cortex, cerebellum, and dentate gyrus. J Neurosci Res 42:674-683.
4. Bushbeck M, Eickhoff J, Sommer MN, Ullrich A. 2002. Phosphotyrosine- specific phosphatase PTP-SL regulates the ERK5 signaling pathway. J Biol Chem 277:29503-29509.
5. Cavanaugh JE, Ham J, Hetman M, Poser S, Yan C, Xia Z. 2001. Differential regulation of mitogen-activated protein kinases ERK1/2 and ERK5 by neurotrophins, neuronal activity, and cAMP in neurons. J Neurosci 21:434-443.
6. Choi HK, Won L, Roback JD, Wainer BH, Heller A. 1992. Specific modulation of dopamine expression in neuronal hybrid cells by primary cells from different brain regions. Proc Natl Acad Sci U S A 89:8943-8947.
7. +-induced dopaminergic neuronal cell death: role of caspases, ROS, and JNK. J Neurosci Res 57:86-94.
8. Choi WS, Yoon SY, Chang II, Choi EJ, Rhim H, Jin BK, Oh TH, Krajewski S, Reed JC, Oh YJ. 2000. Correlation between structure of Bcl-2 and its inhibitory function of JNK and caspase activity in dopaminergic neuronal apoptosis. J Neurochem 74:1621-1626.
9. Ding YM, Jaumotte JD, Signore AP, Zigmond MJ. 2004. Effects of 6-hydroxydopamine on primary cultures of substantia nigra: specific damage to dopamine neurons and the impact of glial cell line-derived neurotrophic factor. J Neurochem 89:776-787.
10. English JM, Pearson G, Baer R, Cobb MH. 1998. Identification of substrates and regulators of the mitogen-activated protein kinase ERK5 using chimeric protein kinases. J Biol Chem 273:3854-3860.
11. Garcia L, Garcia F, Llorens F, Unzeta M, Itarte E, Gomez N. 2002. PP1/PP2A phosphatases inhibitors okadaic acid and calyculin A block ERK5 activation by growth factors and oxidative stress. FEBS Lett 523:90-94.
12. Gille H, Sharrocks AD, Shaw PE. 1992. Phosphorylation of transcription factor p62TCF by MAP kinase stimulates ternary complex formation at c-fos promoter. Nature 358:414-417.
13. Han J, Jiang Y, Li Z, Kravchenko VV, Ulevitch RJ. 1997. Activation of the transcription factor MEF2C by the MAP kinase p38 in inflammation. Nature 386:296-299.
14. Hetman M, Kanning K, Cavanaugh JE, Xia Z. 1999. Neuroprotection by brain-derived neurotrophic factor is mediated by extracellular signal-regulated kinase and phosphatidylinositol 3-kinase. J Biol Chem 274:22569-22580.
15. Hetman M, Cavanaugh JE, Kimelman D, Xia Z. 2000. Role of glycogen synthase kinase-3beta in neuronal apoptosis induced by trophic withdrawal. J Neurosci 20:2567-2574.
16. Hetman M, Hsuan SL, Habas A, Higgins MJ, Xia Z. 2002. ERK1/2 antagonizes glycogen synthase kinase-3beta-induced apoptosis in cortical neurons. J Biol Chem 277:49577-49584.
17. Kamakura S, Moriguchi T, Nishida E. 1999. Activation of the protein kinase ERK5/BMK1 by receptor tyrosine kinases. Identification and characterization of a signaling pathway to the nucleus. J Biol Chem 274:26563-26571.
18. Kato Y, Kravchenko VV, Tapping RI, Han J, Ulevitch RJ, Lee JD. 1997. BMK1/ERK5 regulates serum-induced early gene expression through transcription factor MEF2C. EMBO J 16:7054-7066.
19. Kondoh K, Terasawa K, Morimoto H, Nishida E. 2006. Regulation of nuclear translocation of extracellular signal-regulated kinase 5 by active nuclear import and export mechanisms. Mol Cell Biol 26:1679-1690.
20. Kulich SM, Chu CT. 2001. Sustained extracellular signal-regulated kinase activation by 6-hydroxydopamine: implications for Parkinson's disease. J Neurochem 77:1058-1066.
21. Lin E, Perez RG, Zigmond MJ. 2004. Role of ERK1/2 activation in dopaminergic cell survival in response to oxidative stress. Program No. 93.9. Abstract Viewer/Itinerary Planner. Washington, DC: Society for Neuroscience.
22. Liu L, Cavanaugh JE, Wang Y, Sakagami H, Mao Z, Xia Z. 2003. ERK5 activation of MEF2-mediated gene expression plays a critical role in BDNF-promoted survival of developing but not mature cortical neurons. Proc Natl Acad Sci U S A 100:8532-8537.
23. Lotharius J, Brundin P. 2002. Pathogenesis of Parkinson's disease: Dopamine, vesicles and α-synuclein. Nat Neurosci Rev 3:932-942.
24. Mansour SJ, Resing KA, Candi JM, Hermann AS, Gloor JW, Herskind KR, Wartmann M, Davis RJ, Ahn NG. 1994. Mitogen-activated protein (MAP) kinase phosphorylation of MAP kinase kinase: determination of phosphorylation sites by mass spectrometry and site-directed mutagenesis. J Biochem 116:304-314.
25. Mao Z, Bonni A, Xia F, Nadal-Vicens M, Greenberg ME. 1999. Neuronal activity-dependent cell survival mediated by transcription factor MEF2. Science 286:785-790.
26. Marais R, Wynne J, Treisman R. 1993. The SRF accessory protein Elk-1 contains a growth factor-regulated transcriptional activation domain. Cell 73:381-393.
27. Marinissen MJ, Chiariello M, Pallante M, Gutkind JS. 1999. A network of mitogen-activated protein kinases links G protein-coupled receptors to the c-jun promoter: a role for c-Jun NH2-terminal kinase, p38s, and extracellular signal-regulated kinase 5. Mol Cell Biol 19:4289-4301.
28. Mody N, Leitch J, Armstrong C, Dixon J, Cohen P. 2001. Effects of MAP kinase cascade inhibitors on the MKK5/ERK5 pathway. FEBS Lett 502:21-24.
29. Nakamura K, Uhlik MT, Johnson NL, Hahn KM, Johnson GL. 2006. PB1 domain-dependent signaling complex is required for extracellular signal-regulated kinase 5 activation. Mol Cell Biol 26:2065-2079.
30. Oh JH, Choi WS, Kim JE, Seo JW, O'Malley KL, Oh YJ. 1998. Overexpression of HA-Bax but not Bcl-2 or Bcl-XL attenuates 6-hydroxydopamine-induced neuronal apoptosis. Exp Neurol 154:193-198.
31. +, but not 6-OHDA, induced cell death in a dopaminergic neuronal cell line. Neurobiol Dis 2:157-167.
32. Rameau GA, Akaneya Y, Chiu L, Ziff EB. 2000. Role of NMDA receptor functional domains in excitatory cell death. Neuropharmacology 39:2255-2266.
33. Ranganathan A, Pearson GW, Chrestensen CA, Sturgill TW, Cobb MH. 2006. The MAP kinase ERK5 binds to and phosphorylates p90 RSK. Arch Biochem Biophys 449:8-16.
34. Ricart KC, Fiszman ML. 2001. Hydrogen peroxide-induced neurotoxicity in cultured cortical cells grown in serum-free and serum-containing media. Neurochem Res 26:801-808.
35. Shalizi A, Lehtinen M, Gaudilliere B, Donovan N, Han J, Konishi Y, Bonni A. 2003. Characterization of a neurotrophin signaling mechanism that mediates neuron survival in a temporally specific pattern. J Neurosci 23:7326-7336.
36. Smith AD, Amalric M, Koob GF, Zigmond MJ. 2002. Effect of bilateral 6-hydroxydopamine lesions of the medial forebrain bundle on reaction time. Neuropsychopharmacology 26:756-764.
37. Stanciu M, DeFranco DB. 2002. Prolonged nuclear retention of activated extracellular signal-regulated protein kinase promotes cell death generated by oxidative toxicity of proteasome inhibition in a neuronal cell line. J Biol Chem 277:4010-4017.
38. Ugarte SD, Lin E, Klann E, Zigmond MJ, Perez RG. 2003. Effects of GDNF on 6-OHDA-induced death in a dopaminergic cell line: modulation by inhibitors of PI3 kinase and MEK. J Neurosci Res 73:105-112.
39. Ward CM, Barrow KM, Stern PL. 2004. Significant variations in differentiation properties between independent mouse ES cell lines cultured under defined conditions. Exp Cell Res 293:229-238.
40. Watson FL, Heerssen HM, Bhattacharyya A, Klesse L, Lin MZ, Segal RA. 2001. Neurotrophins use the Erk5 pathway to mediate a retrograde survival response. Nat Neurosci 4:981-988.
41. Wolinsky EJ, Landis SC, Patterson PH. 1985. Expression of noradrenergic and cholinergic traits by sympathetic neurons cultured without serum. J Neurosci 5:1497-1508.
42. Xia Z, Dickens M, Raingeaud J, Davis RJ, Greenberg ME. 1995. Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis. Science 270:1326-1331.
43. Yang CC, Ornatsky OI, McDermott JC, Cruz TF, Prody CA. 1998. Interaction of myocyte enhancer factor 2 (MEF2) with a mitogen- activated protein kinase, ERK5/BMK1. Nucleic Acids Res 26:4771-4777.
44. Zhu JH, Kulich SM, Oury TD, Chu CT. 2002. Cytoplasmic aggregates of phosphorylated extracellular signal-regulated protein kinases in Lewy body diseases. Am J Pathol 161:2087-2098.
45. Zhu JH, Guo F, Shelburne J, Watkins S, Chu CT. 2003. Localization of phosphorylated ERK/MAP kinases to mitochondria and autophagosomes in Lewy body diseases. Brain Pathol 13:473-481.
46. Zigmond MJ, Keefe KA. 1997. Highly selective neurotoxins: basic and clinical applications. New York: Humana Press.